Shire Plc (SHPG)

160.79
2.40 1.50
NASDAQ : Health Technology
Prev Close 158.37
Open 162.87
Day Low/High 159.51 / 162.92
52 Wk Low/High 123.73 / 192.15
Volume 1.72M
Avg Volume 1.45M
Exchange NASDAQ
Shares Outstanding 300.99M
Market Cap 50.13B
EPS 14.30
P/E Ratio 44.55
Div & Yield 1.05 (0.65%)

Latest News

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

U.S. stocks attempted to reverse the global tide Wednesday, with futures improving after better-than-expected earnings from Boeing and Twitter and a spate of multi-billion merger deals at home and abroad.

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

U.S. stock futures point to further losses for Wall Street and global stocks slump on Wednesday; Facebook, Boeing and AMD report earnings; Takeda sweetens offer for Shire.

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

As Wall Street prepares for another rough day, these are the business stories you must know.

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow fell triple digits after starting the day off in the green.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Some Biotech Stocks to Add Exposure To

Some Biotech Stocks to Add Exposure To

Secondary offerings create buying opportunities.

Three Biotech Names to Consider

Three Biotech Names to Consider

A look at three names to consider in the biotech and biopharma space.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

Oil remained near a three-year high despite falling back slightly on Thursday.

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

M&A activity kicks into high gear going into the final days of the first quarter. If the broader stock market doesn't pop on this news, it would be a red flag.

The Dow Falls Into Wednesday's Close

The Dow Falls Into Wednesday's Close

Strength in the morning yields to weakness in the afternoon session as stocks are sold off Wednesday.

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Takeda Pharmaceutical Confirms Takeover Interest in U.K.-Listed Shire Plc

Shire Pharmaceuticals shares hit a year-to-date high Wednesday after Japan's biggest drugmaker, Takeda, confirmed it may make a takeover approach for the U.K.-listed group.

Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates

Quanterix Uses JPMorgan Healthcare Conference to Scout Sales Candidates

With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.

The New #35 Most Shorted Nasdaq 100 Component: Shire

The New #35 Most Shorted Nasdaq 100 Component: Shire

The most recent short interest data has been released for the 12/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

10 Biotech Stocks Investors Should Put on Their Shopping List for 2018

Biotech M&A activity will pick up markedly in 2018, and these companies are likely to be the most active in that space.

10 Biotech Stocks to Watch in 2018

10 Biotech Stocks to Watch in 2018

There are a variety of players that should be active in the M&A space next year.

Roche Stock Surges on Trial Successes in Cancer, Haemophilia

Roche Stock Surges on Trial Successes in Cancer, Haemophilia

Roche sees success in trials for its cancer and hemophilia drugs

Weekly Roundup

The markets' climb hits a detour at the end of the week. In the portfolio, after adding five names to the bullpen, we promoted one of them to the portfolio.

Billionaire Hedge Fund Manager Leon Cooperman Gave His Top 5 Cheap Stocks

Billionaire Hedge Fund Manager Leon Cooperman Gave His Top 5 Cheap Stocks

Cooperman founded Omega Advisers in 1991.

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Evercore ISI analyst Josh Schimmer is bullish on biotech.

TheStreet Quant Rating: C (Hold)